1.1 Research Objective

1.2 Product Overview

1.3 Market Segmentation

2.1 Qualitative Research
2.1.1 Primary & Secondary Sources

2.2 Quantitative Research
2.2.1 Primary & Secondary Sources

2.3 Breakdown of Primary Research Respondents, By Region

2.4 Assumption for the Study

2.5 Market Size Estimation

2.6. Data Triangulation

Executive Summary: Europe Dental Bone Grafts and Substitutes Market

4.1. Industry Value Chain Analysis
4.1.1. Material provider
4.1.2. Manufacturer
4.1.3. Service Provider
4.1.4. End User

4.2. Industry Outlook
4.2.1. Overview of Dental Bone Grafts and Substitutes Market
4.2.1.1. List of Major DSOs
4.2.1.2. Recent Mergers & Acquisitions 
4.2.1.3. List of Major HMOs 
4.2.2. Trends and Developments- Dental Bone Grafts and Substitutes Market
4.2.4. Funding Process for Bone Grafts and Substitutes 

4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Degree of Competition

4.4. Market Dynamics and Trends
4.4.1. Growth Drivers
4.4.2. Restraints
4.4.3. Challenges
4.4.3. Key Trends

4.5. Covid-19 Impact Assessment on Market Growth Trend

4.6. Market Growth and Outlook
4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 - 2030
4.6.1. Price Trend Analysis
4.6.1.1 Top Players, By Country, By Product, By SKU*

4.7. Competition Dashboard
4.7.1. Market Concentration Rate
4.7.2. Company Market Share Analysis (Value %), 2021
4.7.3. Competitor Mapping  

5.1. Key Insights

5.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
5.2.1. Xenograft
5.2.2. Autograft
5.2.3. Allograft 
5.2.4. Synthetic analysis

6.1. Key Insights

6.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
6.2.1. Natural bone grafts
6.2.1.1. Autologous bone grafts
6.2.1.1.1. Cancellous autografts
6.2.1.1.2. Cortical autografts
6.2.1.2. Allogeneic bone grafts
6.2.1.2.1. Cancellous allografts
6.2.1.2.2. Demineralized bone matrix (DBM)
6.2.2. Synthetic bone graft substitutes
6.2.2.1. Calcium sulphate
6.2.2.2. Calcium phosphate ceramics (CaP ceramics)
6.2.2.2.1. Tricalcium phosphate (TCP)
6.2.2.2.2. Biphasic calcium phosphate (BCP)
6.2.2.3. Calcium phosphate cements (CPC)
6.2.2.4. Others
6.2.3. Others

7.1. Key Insights

7.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
7.2.1. Research & Development
7.2.2. Clinical Applications

8.1. Key Insights

8.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
8.2.1. Biopharmaceutical Companies
8.2.2. Contract Research Organizations
8.2.3. Contract Manufacturing Organizations
8.2.4. Academic & Research Institutes

9.1. Key Insights

9.2. Market Size and Forecast, 2017 - 2030 (US$ Mn)
9.2.1. The UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Netherlands
9.2.7. Turkey
9.2.8. Rest of Europe

10.1. Country Profile
10.1.2. Major DSOs
10.1.2. HMOs
10.1.3. Market Dynamics 
10.1.4. Key Players Market Share Analysis 

10.2. Key Insights
10.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
10.2.1. By Treatment Type
10.2.2. By Application
10.2.3. By End User

11.1. Country Profile
11.1.1. Major DSOs
11.1.2. HMOs
11.1.3. Market Dynamics 
11.1.4. Key Players Market Share Analysis 

11.2. Key Insights
11.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
11.3.1. By Treatment Type
11.3.2. By Application
11.3.3. By End User

12.1. Country Profile
12.1.1. Major DSOs
12.1.2. HMOs
12.1.3. Market dynamics 
12.1.4. Key players Market share Analysis 

12.2. Key Insights
12.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
12.3.1. By Treatment Type
12.3.2. By Application
12.3.3. By End User

13.1. Country Profile
13.1.1. Major DSOs
13.1.2. HMOs
13.1.3. Market dynamics 
13.1.4. Key players Market share Analysis 

13.2. Key Insights

13.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
13.3.1. By Treatment Type
13.3.2. By Application
13.3.3. By End User

14.1. Country Profile
14.1.1. Major DSOs
14.1.2. HMOs
14.1.3. Market dynamics 
14.1.4. Key players Market share Analysis 

14.2. Key Insights

14.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
14.3.1. By Treatment Type
14.3.2. By Application
14.3.3. By End User

15.1. Country Profile
15.1.1. Major DSOs
15.1.2. HMOs
15.1.3. Market dynamics 
15.1.4. Key players Market share Analysis 

15.2. Key Insights

15.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
15.3.1. By Treatment Type
15.3.2. By Application
15.3.3. By End User

16.1. Country Profile
16.1.1. Major DSOs
16.1.2. HMOs
16.1.3. Market dynamics 
16.1.4. Key players Market share Analysis 

16.2. Key Insights

16.3. Market Size and Forecast, 2017 - 2030 (US$ Mn)
16.3.1. By Treatment Type
16.3.2. By Application
16.3.3. By End User

17.1. Ivoclar Vivadent
17.2. Zimmer Biomet
17.3. DENTSPLY SIRONA
17.4. Nobel Biocare
17.7. Medtronic 
17.8. BioHorizons IPH, Inc. 
17.9. ACE Surgical Supply Company 
17.10. Geisclich Pharma AG
17.11. Straumann Group